ACTRN12611000981921进行中（未招募）2 期
A Pilot randomised controlled trial investigating the safety and efficacy of a permissive temperature strategy against a paracetamol-based strategy in critically ill patients with known or suspected infection
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 16 Years 至 o limit（—）
- 性别
- All
入选标准
- •Patients are eligible to be included in the study only if they meet the following criteria at the time of randomisation:
- •1.Age greater than or equal to16 years
- •2.Standardised body temperature greater than or equal to 38.0 degrees within the previous 12 hours.
- •3.Receiving antimicrobial therapy for a known or suspected infection (this does NOT include post-operative patients who are receiving antibiotics for the purposes of prophylaxis rather than treatment)
排除标准
- •Patients will be excluded from the study if they meet ANY of the following criteria:
- •1.AST or ALT greater than five times the upper limit of normal OR bilirubin greater than twice the upper limit of normal OR any other contraindication to 4gm paracetamol per day
- •2.a requirement for ongoing NSAID use (in excess of low dose aspirin);
- •3.evidence of acute brain injury during the current hospital admission (defined as any acute traumatic brain injury, subarachnoid haemorrhage, acute ischaemic stroke, acute intracerebral haemorrhage, or acute intracranial infection); hyperthermic syndromes (including heat stroke; current biochemical evidence of thyrotoxicosis (thyroid function tests are not required prior to recruitment into the trial unless clinically indicated); malignant hyperthermia, neuroleptic malignant syndrome, or other drug-induced hyperthermia)
- •4.admission to ICU following a cardiac arrest which is currently being treated with therapeutic hypothermia;
- •5.there is a limitation of therapy order or aggressive treatment is deemed unsuitable
- •6.patients who are moribund and, in whom, death is perceived to be imminent (within 24 hours);
- •7.any patient with rhabdomyolysis that is deemed by the treating clinician to be clinically significant.
- •8.any patient transferred from another ICU who fulfilled all inclusion criteria in the other ICU and spent >12 hours in the other ICU prior to transfer
- •9.any patient who is pregnant;
- •10.previously randomised into the HEAT trial or previously eligible for enrolment during the current ICU admission but not enrolled in the study (i.e. patients who were not enrolled within 12 hours of onset of fever in association with satisfying other eligibility criteria may not be enrolled at a later point in the ICU admission)
研究者
相似试验
已完成
不适用
Self-management and Multiple Sclerosis: The impact of a community-based exercise and education programMultiple SclerosisACTRN12613000245796Melbourne Health24
尚未招募
不适用
A pilot randomized controlled trial investigating the feasibility, acceptability and preliminary (cost-)effectiveness and implementation of a combined lifestyle intervention for outpatients with a severe or chronic psychiatric illness (CHAPTER)Mental disorderNL-OMON53239entis (Groningen)40
已完成
不适用
Do customised fit shoes increase physical activity in children with Down syndrome?Physical activity in Down syndromeFoot health in Down syndromePhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationHuman Genetics and Inherited Disorders - Down's syndromeACTRN12616001118493Shannon Munteanu30
尚未招募
不适用
A mobile health application for people in remote and rural Queensland who have experienced a cardiovascular event.Coronary Heart DiseaseCardiovascular - Coronary heart diseaseCardiovascular diseaseACTRN12621001229864Menzies Health Institute Queensland (MHIQ)60
已完成
不适用
A randomised controlled pilot trial investigating the feasibility of monitoring patients with or at risk for cardiovascular disease who have symptoms suspected of COVID-19 by pulse oximetry at homeNL-OMON54917niversitair Medisch Centrum Utrecht50